Literature DB >> 11828208

Indirect CT venography following CT pulmonary angiography: spectrum of CT findings.

Cesario Ciccotosto1, Lawrence R Goodman, Lacey Washington, Francisco A Quiroz.   

Abstract

SUMMARY: Pulmonary embolism (PE) and deep venous thrombosis (DVT) represent two manifestations of the same syndrome, venous thromboembolism. Contrast-enhanced computed tomography (CT) angiography is a practical, efficient alternative to conventional imaging for PE. Following the pulmonary examination, the inferior vena cava (IVC) and the iliac, femoral, and popliteal veins can be studied with CT without additional intravenous contrast administration. Indirect CT venography (CTV) after CT pulmonary angiography (CTPA) simplifies and shortens venous thromboembolism work-up. Initial studies indicate that CTV is comparable to ultrasound in the evaluation of femoral/popliteal DVT. CTV has the advantage of evaluating the iliac veins and inferior vena cava, vessels poorly seen on sonography and venography. Combining CTV with CTPA increases confidence in withholding treatment when results for both the pulmonary arteries and leg veins are negative and increases the diagnosis of venous thromboembolism by 25% over CTPA alone. This pictorial essay will review the normal venous anatomy, CTV technique, and the findings of acute and chronic DVT. Interpretive pitfalls and alternative diagnoses are also reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11828208     DOI: 10.1097/00005382-200201000-00002

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  8 in total

Review 1.  Comprehensive evaluation of patients suspected with deep vein thrombosis using indirect CT venography with multi-detector row technology: from protocol to interpretation.

Authors:  Yen-Ting Lin; I-Chen Tsai; Wei-Lin Tsai; Min-Chi Chen; Pao-Chun Lin; Si-Wa Chan; Clayton Chi-Chang Chen
Journal:  Int J Cardiovasc Imaging       Date:  2010-08-25       Impact factor: 2.357

2.  Design and Characterization of an Ultrasound Transducer for Combined Histotripsy-Thrombolytic Therapy.

Authors:  Adam D Maxwell; Kevin J Haworth; Christy K Holland; Samuel A Hendley; Wayne Kreider; Kenneth B Bader
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2021-12-31       Impact factor: 2.725

3.  Venous Segmental Flow Changes after Superficial Venous Intervention Demonstrating by Quantitative Phase-Contrast Magnetic Resonance Analysis: Preliminary Data from a Longitudinal Cohort Study.

Authors:  Chien-Wei Chen; Yuan-Hsi Tseng; Chih-Chen Kao; Yeh Giin Ngo; Chung-Yuan Lee; Teng-Yao Yang; Yu-Hui Lin; Yao-Kuang Huang
Journal:  J Pers Med       Date:  2022-06-19

4.  Real-time MR with TrueFISP for the detection of acute pulmonary embolism: initial clinical experience.

Authors:  Alexander Kluge; Clemens Müller; Jochen Hansel; Tibo Gerriets; Georg Bachmann
Journal:  Eur Radiol       Date:  2003-12-05       Impact factor: 5.315

5.  Indirect computed tomography venography: a report of vascular opacification.

Authors:  Patrick R Burnside; Edward Green; Jeffrey A Kline
Journal:  Emerg Radiol       Date:  2010-05

6.  Detection of Deep Vein Thrombosis by Follow-up Indirect Computed Tomography Venography after Pulmonary Embolism.

Authors:  Hye Jin Lee; Seung Ick Cha; Kyung Min Shin; Jae Kwang Lim; Seung Soo Yoo; Shin Yup Lee; Jaehee Lee; Chang Ho Kim; Jae Yong Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-12-13

7.  Usefulness of the advanced monoenergetic image reconstruction in dual-energy computed tomography for detecting the perforator vein of lower extremity varix.

Authors:  Hidekazu Matsumae; Motoo Nakagawa; Yoshiyuki Ozawa; Miki Asano; Masashi Shimohira; Yuta Shibamoto
Journal:  Acta Radiol Open       Date:  2020-04-15

Review 8.  Acute Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension: Clinical and Serial CT Pulmonary Angiographic Features.

Authors:  Junho An; Yoojin Nam; Hyoun Cho; Jeonga Chang; Duk-Kyung Kim; Kyung Soo Lee
Journal:  J Korean Med Sci       Date:  2022-03-14       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.